Akiko Saito

6.6k total citations · 1 hit paper
237 papers, 3.9k citations indexed

About

Akiko Saito is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Akiko Saito has authored 237 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Hematology, 57 papers in Public Health, Environmental and Occupational Health and 44 papers in Molecular Biology. Recurrent topics in Akiko Saito's work include Acute Lymphoblastic Leukemia research (49 papers), Acute Myeloid Leukemia Research (36 papers) and Lymphoma Diagnosis and Treatment (29 papers). Akiko Saito is often cited by papers focused on Acute Lymphoblastic Leukemia research (49 papers), Acute Myeloid Leukemia Research (36 papers) and Lymphoma Diagnosis and Treatment (29 papers). Akiko Saito collaborates with scholars based in Japan, United States and Canada. Akiko Saito's co-authors include Toshiya Sakata, Keizo Horibe, Craig C. Earle, Eiichi Tomita, Yasutoshi Muto, Takuji Tanaka, Ken Takasaki, Mitsuo Ninomiya, Toshiyuki Nakamura and Hisataka Moriwaki and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Circulation.

In The Last Decade

Akiko Saito

215 papers receiving 3.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevention of Second Primary Tumors by an Acyclic Retinoid, Polyprenoic Acid, in Patients with Hepatocellular Carcinoma

1996 513 citations Akiko Saito et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Akiko Saito Japan	34	972	779	762	715	499	237	3.9k
Barton A. Kamen United States	31	2.0k 2.0×	548 0.7×	933 1.2×	1.2k 1.7×	636 1.3×	99	5.1k
Luis Isola United States	33	693 0.7×	2.0k 2.6×	701 0.9×	907 1.3×	419 0.8×	99	4.0k
Abha A. Gupta Canada	38	737 0.8×	382 0.5×	780 1.0×	1.2k 1.6×	1.1k 2.1×	241	5.0k
Amos Toren Israel	33	1.7k 1.8×	893 1.1×	441 0.6×	1.1k 1.5×	461 0.9×	200	4.8k
Hee Young Shin South Korea	32	676 0.7×	889 1.1×	651 0.9×	525 0.7×	547 1.1×	258	3.9k
Klaus Müller Denmark	38	1.5k 1.5×	696 0.9×	292 0.4×	637 0.9×	373 0.7×	217	5.5k
Stacey L. Berg United States	41	1.6k 1.7×	434 0.6×	710 0.9×	1.7k 2.4×	737 1.5×	149	5.0k
William Harmon United States	42	409 0.4×	222 0.3×	1.5k 2.0×	839 1.2×	559 1.1×	121	6.1k
Clemens Tempfer Austria	52	1.9k 1.9×	261 0.3×	930 1.2×	1.9k 2.7×	676 1.4×	374	9.2k
Daohai Yu United States	40	1.4k 1.5×	304 0.4×	371 0.5×	1.4k 1.9×	150 0.3×	175	5.5k

Countries citing papers authored by Akiko Saito

Since Specialization

Citations

This map shows the geographic impact of Akiko Saito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akiko Saito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akiko Saito more than expected).

Fields of papers citing papers by Akiko Saito

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akiko Saito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akiko Saito. The network helps show where Akiko Saito may publish in the future.

Co-authorship network of co-authors of Akiko Saito

This figure shows the co-authorship network connecting the top 25 collaborators of Akiko Saito. A scholar is included among the top collaborators of Akiko Saito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akiko Saito. Akiko Saito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nakabayashi, Kazuhiko, Masahiko Ikeda, Akiko Saito, et al.. (2025). Familial Alveolar Capillary Dysplasia With Misalignment of Pulmonary Veins Caused by Paternal FOXF1 Upstream Enhancer Deletion: A Case Report. American Journal of Medical Genetics Part A. 197(7). e64056–e64056.

Shima, Haruko, Akihiko Tanizawa, Masaki Ito, et al.. (2024). Growth retardation and adult height in pediatric patients with chronic-phase chronic myeloid leukemia treated with tyrosine kinase inhibitors. Leukemia. 39(2). 508–511.

Kojima, Yasushi, Yuya Hisada, Akiko Saito, et al.. (2023). Main causes of death in advanced biliary tract cancer. Cancer Medicine. 12(9). 10889–10898. 1 indexed citations

Ishida, Hisashi, Toshihiko Imamura, Takashi Ishihara, et al.. (2023). Impact of asparaginase discontinuation on outcomes of children with acute lymphoblastic leukaemia receiving the Japan Association of Childhood Leukaemia Study ALL‐02 protocol. British Journal of Haematology. 201(6). 1200–1208. 4 indexed citations

Ogura, Hiroyuki, Takashi Nakamura, Takenobu Ishii, et al.. (2023). Mechanical stress-induced FGF-2 promotes proliferation and consequently induces osteoblast differentiation in mesenchymal stem cells. Biochemical and Biophysical Research Communications. 684. 149145–149145. 9 indexed citations

Shimokawahara, Hiroto, Takumi Inami, Kayoko Kubota, et al.. (2023). Protocol for a multicentre, double-blind, randomised, placebo-controlled trial of riociguat on peak cardiac index during exercise in patients with chronic thromboembolic pulmonary hypertension after balloon pulmonary angioplasty (THERAPY-HYBRID-BPA trial). BMJ Open. 13(7). e072241–e072241. 7 indexed citations

Saito, Akiko & Masahide Kondo. (2023). Maternal and Child Health handbook and under-6 child overweight in greater Jakarta, Indonesia: a cross-sectional web-based survey. BMC Nutrition. 9(1). 40–40. 2 indexed citations

Mori, Tetsuya, Tetsuya Mori, Tomoo Osumi, et al.. (2023). Rituximab with standard LMB chemotherapy in pediatric high‐risk mature B‐cell non‐Hodgkin lymphoma: A report from the JPLSG B‐NHL14 trial. European Journal Of Haematology. 112(4). 585–593. 1 indexed citations

Shima, Haruko, Akiko Kada, Akihiko Tanizawa, et al.. (2022). Discontinuation of tyrosine kinase inhibitors in pediatric chronic myeloid leukemia. Pediatric Blood & Cancer. 69(8). e29699–e29699. 14 indexed citations

10.

Nakayama, Hideki, Chitose Ogawa, Masahiro Sekimizu, et al.. (2022). A phase I study of inotuzumab ozogamicin as a single agent in pediatric patients in Japan with relapsed/refractory CD22-positive acute lymphoblastic leukemia (INO-Ped-ALL-1). International Journal of Hematology. 116(4). 612–621. 4 indexed citations

11.

Moritake, Hiroshi, Shiro Tanaka, Takako Miyamura, et al.. (2020). The outcomes of relapsed acute myeloid leukemia in children: Results from the Japanese Pediatric Leukemia/Lymphoma Study Group AML‐05R study. Pediatric Blood & Cancer. 68(1). e28736–e28736. 12 indexed citations

12.

Yokoyama, Akihiro, Akiko Kada, Akiko Saito, et al.. (2019). Phase II Study of Treatment for Newly Diagnosed Multiple Myeloma Patients Over 75 Years Old with Alternating Bortezomib/dexamethasone and Lenalidomide/dexamethasone: the MARBLE Trial.. PubMed. 73(6). 547–552. 1 indexed citations

13.

Hagiwara, Shotaro, Hirokazu Nagai, Tomoko Uehira, Akiko Saito, & Seiji Okada. (2019). Autologous peripheral blood stem cell transplantation for relapsed/refractory HIV-associated lymphoma: a phase II clinical study. International Journal of Hematology. 111(3). 434–439. 6 indexed citations

14.

Kitagawa, Chiyoe, Akiko Kada, Akiko Saito, Yukito Ichinose, & Hideo Saka. (2018). Rationale and Design of a Randomized Phase 2 Trial of Gefitinib Plus Bevacizumab vs Gefitinib Alone in Patients with Epidermal Growth Factor Receptor Mutant Non-Squamous Non-Small-Cell Lung Cancer: Study Protocol. The Kurume Medical Journal. 65(2). 77–81. 2 indexed citations

15.

Miyata, Yasuhiko, Akiko Saito, Takahiro Yano, et al.. (2018). R-mini CHP in ≥80-year-old Patients with Diffuse Large B-cell Lymphoma: A Multicenter, Open-label, Single-arm Phase II Trial Protocol.. PubMed. 72(3). 315–318. 2 indexed citations

16.

Schüz, Joachim, Kathrine Grell, Sally E. Kinsey, et al.. (2012). Extremely low-frequency magnetic fields and survival from childhood acute lymphoblastic leukemia: an international follow-up study. Blood Cancer Journal. 2(12). e98–e98. 8 indexed citations

17.

Ichihara, Shu, Suzuko Moritani, Masaki Hasegawa, et al.. (2011). Measurement of human epidermal growth factor receptor type-2 extracellular domain and cancer antigen 15–3 levels in needle washout fluid: a potential adjunct to the cytological diagnosis of breast cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 458(5). 547–559. 1 indexed citations

18.

Saito, Akiko, Mary Beth Landrum, Bridget A. Neville, et al.. (2011). Hospice Care and Survival among Elderly Patients with Lung Cancer. Journal of Palliative Medicine. 14(8). 929–939. 88 indexed citations

19.

Uruno, Akira, Akira Sugawara, Masataka Kudo, et al.. (2008). Stimulatory Effects of Low-Dose 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor Fluvatatin on Hepatocyte Growth Factor–Induced Angiogenesis: Involvement of p38 Mitogen-Activated Protein Kinase. Hypertension Research. 31(11). 2085–2096. 16 indexed citations

20.

Sato, Yoshiaki, Keiko Nakanishi, Yoshihito Tokita, et al.. (2007). A highly sulfated chondroitin sulfate preparation, CS‐E, prevents excitatory amino acid‐induced neuronal cell death. Journal of Neurochemistry. 104(6). 1565–1576. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact